Foreword
Introduction: Immune pharmacology of skin diseases
Neoral® (cyclosporin) in dermatology: technical aspects*
Clinical aspects: preliminary experience with a novel oral formulation of cyclosporin (Neoral®)
Comparison of the steady state pharmacokinetics of two formulations of cyclosporin in patients with atopic dermatitis*
The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens
Treatment of severe atopic dermatitis in childhood with cyclosporin
Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis*
Individualized short-course cyclosporin therapy in psoriasis
Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin*
Cyclosporin in less common immune-mediated skin diseases